More Stories
Richmond pharma company makes leadership appointments
Kaléo makes five hires, promotions
Published
Richmond-based pharmaceutical company Kaléo announced Tuesday five executive leadership appointments and promotions. Joining Kaléo from Boston Scientific, where he served as the senior vice president of corporate compliance and privacy
Chesterfield pharma company enters $600M federal plea deal
Indivior Solutions Inc. settlement stems from false safety claims about opioid addiction treatment drug
Published
Less than one month after former Indivior PLC CEO Shaun Thaxter pleaded guilty in federal court in Abingdon to a misdemeanor criminal charge related to the marketing of the Chesterfield
Advertisement
Ex Chesterfield pharma CEO pleads guilty in federal opioid treatment investigation
Indivior PLC CEO Shaun Thaxter stepped down Monday
Published
Shaun Thaxter, former CEO of Chesterfield County-based pharmaceutical manufacturer Indivior PLC, pleaded guilty Tuesday in federal court in Abingdon to a misdemeanor criminal charge related to the U.S Justice Department’s
Trump administration chooses RVA pharma startup for $354M COVID-19 contract
Phlow Corp. will create domestic supply chain for coronavirus drugs
Published
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic
Richmond pharmaceutical company expands into Canada
Kaléo will begin selling its epinephrine auto-injector in Canadian pharmacies this month
Published
Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic reactions will be available in